Streetbeat News

Earnings

NARI

Inari Medical's shares surged following the announcement of Q1 sales results that exceeded expectations and the issuance of FY24 revenue guidance surpassing estimates.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 8:33 pm

OI

O-I Glass shares dropped following the announcement of disappointing Q1 sales results and a reduction in the forecast for FY24 adjusted EPS.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 8:32 pm

FORR

Forrester Research (FORR) reported Q1 2024 earnings of $0.14 per share, missing the consensus estimate of $0.21, and sales of $100.077M, below the $104.212M estimate. This represents a decrease from the previous year's earnings and sales.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 8:32 pm

CCCS

CCC Intelligent Solutions projects Q2 revenue to be between $228.5M-$230.5M, slightly below the estimated $230.92M. For FY24, the company forecasts revenue to range from $944M-$950M, closely aligning with the $946.97M estimate.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 8:31 pm

MFIN

Medallion Financial (MFIN) reported Q1 2024 earnings of $0.42 per share, surpassing the $0.39 estimate, a 37.31% decrease from last year's $0.67. Sales reached $53.320M, beating the $49.702M estimate, marking a 16.71% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 8:31 pm

LEG

Leggett & Platt's shares dropped following the announcement of disappointing Q1 financial results, falling short of expectations.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 8:31 pm

LEG

RCKY

SBUX

In Tuesday's after-market session, consumer discretionary stocks saw significant movements. Rocky Brands (RCKY) led the gainers with a 24.2% increase following their Q1 earnings release. Other notable gainers included Qurate Retail (QRTEA) and Sweetgreen (SG). On the downside, Starbucks (SBUX) experienced a 10% drop after their Q2 earnings announcement, with Leggett & Platt (LEG) and Foresight Autonomous (FRSX) also seeing declines. The movements reflect the market's reaction to recent earnings reports and overall market conditions.

Portfolio Pulse from Benzinga Insights

April 30, 2024 | 8:31 pm

CC

Chemours (NYSE:CC) reported Q1 2024 adjusted earnings per share (EPS) of $0.32, surpassing the analyst consensus estimate of $0.18 by 77.78%. However, this represents a 67.35% decrease from the $0.98 EPS reported in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 8:31 pm

AXNX

Axonics (NASDAQ:AXNX) reported Q1 EPS of $(0.38), missing the $(0.08) estimate by 375%, and a 100% decrease from last year's $(0.19) per share. However, their quarterly sales of $91.41M exceeded estimates by 2.03%, marking a 29.38% increase from last year's $70.65M.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 8:31 pm

CCM

CVRX

POAI

TMDX

In Tuesday's after-market session, several healthcare stocks showed significant movement. Predictive Oncology led the gainers with a 36.4% increase, while Concord Medical Services experienced the largest drop, declining by 23.3%. Notably, TransMedics Group and CVRx reported their Q1 earnings, influencing their stock movements.

Portfolio Pulse from Benzinga Insights

April 30, 2024 | 8:31 pm